phase readout
saveNCT04023227: Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Novartis Pharmaceuticals. Phase: PHASE4. Conditions: Chagas Disease, Heart Failure
view source ↗
comments(0)
5-min edit window · permanent after that